These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency. Evans VA, van der Sluis RM, Solomon A, Dantanarayana A, McNeil C, Garsia R, Palmer S, Fromentin R, Chomont N, Sékaly RP, Cameron PU, Lewin SR. AIDS; 2018 Jul 17; 32(11):1491-1497. PubMed ID: 29746296 [Abstract] [Full Text] [Related]
4. Combination Immune Checkpoint Blockade to Reverse HIV Latency. Van der Sluis RM, Kumar NA, Pascoe RD, Zerbato JM, Evans VA, Dantanarayana AI, Anderson JL, Sékaly RP, Fromentin R, Chomont N, Cameron PU, Lewin SR. J Immunol; 2020 Mar 01; 204(5):1242-1254. PubMed ID: 31988180 [Abstract] [Full Text] [Related]
5. Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs. Ren Y, Huang SH, Macedo AB, Ward AR, Alberto WDC, Klevorn T, Leyre L, Copertino DC, Mota TM, Chan D, Truong R, Rohwetter T, Zumbo P, Dündar F, Betel D, Kovacs C, Benko E, Bosque A, Jones RB. J Virol; 2021 Jul 12; 95(15):e0242520. PubMed ID: 33980597 [Abstract] [Full Text] [Related]
6. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, Van Driessche B, Gatot JS, Cherrier T, Pianowski LF, Gama L, Schwartz C, Vila J, Burny A, Clumeck N, Moutschen M, De Wit S, Peterlin BM, Rouzioux C, Rohr O, Van Lint C. PLoS Pathog; 2015 Jul 12; 11(7):e1005063. PubMed ID: 26225566 [Abstract] [Full Text] [Related]
8. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages. Hany L, Turmel MO, Barat C, Ouellet M, Tremblay MJ. J Virol; 2022 Feb 23; 96(4):e0195321. PubMed ID: 34878918 [Abstract] [Full Text] [Related]